Clinical trial
Phase 1 Clinical Trial to Establish the Safety and Feasibility of Transplants of Umbilical Cord Blood Mononuclear Cells in Chronic Ischemic Stroke
NCT01673932 is registered in ClinicalTrials.gov with China Spinal Cord Injury Network as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Phase 1 Clinical Trial to Establish the Safety and Feasibility of Transplants of Umbilical Cord Blood Mononuclear Cells in Chronic Ischemic Stroke
- Lead sponsor
- China Spinal Cord Injury Network
- Phase
- Phase 1
- Overall status
- Unknown status
- Start date
- October 31, 2012
- Completion date
- July 31, 2019
- Enrollment
- 12 (estimated)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.